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Abstract
Background: Fibromyalgia (FM) is a prevalent and disabling disorder characterized by a history of widespread pain
for at least three months. Pain is considered a complex experience in which affective and cognitive aspects are
crucial for prognosis. The aim of this study is to assess the importance of pain-related psychological constructs on
function and pain in patients with FM.
Methods
Design: Multicentric, naturalistic, one-year follow-up study.
Setting and study sample. Patients will be recruited from primary care health centres in the region of Aragon, Spain.
Patients considered for inclusion are those aged 18-65 years, able to understand Spanish, who fulfil criteria for
primary FM according to the American College of Rheumatology, with no previous psychological treatment.
Measurements: The variables measured will be the following: main variables (pain assessed with a visual analogue
scale and with sphygmomanometer and general function assessed with Fibromyalgia Impact Questionnaire, and),
psychological constructs (pain catastrophizing, pain acceptance, mental defeat, psychological inflexibility, perceived
injustice, mindfulness, and positive and negative affect), and secondary variables (sociodemographic variables,
anxiety and depression assessed with Hospital Anxiety and Depression Scale, and psychiatric interview assessed
with MINI). Assessments will be carried at baseline and at one-year follow-up.
Main outcome: Pain Visual Analogue Scale.
Analysis: The existence of differences in socio-demographic, main outcome and other variables regarding pain-
related psychological constructs will be analysed using Chi Square test for qualitative variables, or Student t test or
variance analysis, respectively, for variables fulfilling the normality hypothesis. To assess the predictive value of pain-
related psychological construct on main outcome variables at one-year follow-up, use will be made of a logistic
regression analysis adjusted for socio-demographic and clinical variables. A Spearman Rho non-parametric
correlation matrix will be developed to determine possible overlapping between pain-related psychological
constructs.
Discussion: In recent years, the relevance of cognitive and affective aspects for the treatment of chronic pain, not
only in FM but also in other chronic pain diseases, has been widely acknowledged. However, the relative
importance of these psychological constructs, the relationship and possible overlapping between them, or the
exact meaning of them in pain are not enough known.
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Fibromyalgia (FM) is a prevalent and disabling disorder
characterized by a history of widespread pain for at least
three months and patient reporting of tenderness in at
least 11 out of 18 defined tender points when digitally
palpated with about 4 kg per unit area of force [1]. In
addition to pain, the patient suffers from other symp-
toms such as non-restorative sleep, paraesthesia, difficul-
ties in concentration and memory, stiffness, depression
and anxiety [2]. FM is a common disorder; its preva-
lence within the community has been established in the
range of 2-3%, predominantly in women in their third
to fifth decade [3]. The aetiology of FM is uncertain but
the existence of central sensitization is widely accepted
[4]. Many treatments have been used in these patients
but their efficacy is rather limited [5]. Due to its high
prevalence, severe disability, low quality of life for the
patient and significant health costs, FM is considered a
public health problem [6,7].
Pain is the most common and disabling symptom in
FM. The neurobiology of the pain process in FM using
neuroimage techniques has developed greatly in recent
years, identifying what has been called “pain matrix”,
which includes the primary and secondary sensory-
motor cortex, insula, anterior cingulate, thalamus,
dorso-lateral prefrontal cortex and basal ganglia [8-10].
Pain is considered a subjective and complex experi-
ence, in which affective and cognitive aspects are crucial
f o rp r o g n o s i s .A tp r e s e n t ,c l a ssical approaches focusing
on modifying coping strategies [11] or on the cognitive
restructuring of pain [12] are being widened to include
other treatments based on pain acceptation and other
psychological constructs. Some of the most important of
these constructs are the following:
- Pain catastrophizing: This is the most studied pain-
related construct. It has been described as an exagger-
ated negative orientation towards pain stimuli. It is
made up of three dimensions: a) rumination: incapacity
to avoid thinking about pain; b) magnification: exaggera-
tion of the impact that pain produces; and c) helpless-
ness: the feeling that one cannot free without overcome
pain [13]. Some of the consequences that have been
associated with pain catastrophizing in patients with
chronic pain are more intense pain, heightened pain
behaviour, greater consumption of analgesics, reduced
involvement in daily activities, occupational disability
and suicidal ideation [13,14].
- Pain Acceptance [15,16]: This is one of the most
promising and valuable pain-related constructs. It comes
from contextual or third wave psychotherapies and
involves the individual reducing unsuccessful attempts
to avoid or control pain and focusing instead on partici-
pation in valued activities and the pursuit of personally
relevant goals. Some studiesh a v ed e m o n s t r a t e dt h a t
patients with chronic pain and high pain acceptance
present less pain, anxiety and depression, and better
occupational status. Acceptation is associated with bet-
ter adaptation to pain independently of pain severity,
anxiety or depression.
- Mental defeat [17]: This is a recently described cog-
nitive phenomenon not previously assessed in chronic
pain, but thoroughly studied in other disorders such as
depression and post-traumatic stress disorder. It can be
defined as the perceived loss of autonomy in the face of
uncontrollable traumatic events, resulting in the person
giving up efforts to retain identity and self-will. With
regard to pain, mental defeat can be considered a type
of self-processing in which repeated episodes of persis-
tent and disabling pain generate negative thoughts on
pain and oneself.
- Pain psychological inflexibility [18]: From the point
of view of third-generation psychotherapies such as
acceptation and commitment therapy (ACT), observing
external phenomena separately from our thoughts is
crucial if we are to act in accordance with our aims and
values. The inability to maintain our values in the pre-
sence of painful or disabling physical symptoms, emo-
tions and thoughts has been called psychological
inflexibility.
- Perceived injustice [19]: In situations in which the
injury or disease has been produced as a result of negli-
gence or a mistake caused by others (at least from the
patient’s point of view), the victim experiences his life
with a feeling of injustice. The key point in this regard is
the feeling of unnecessary suffering that can be blamed
on another, requiring reparation from society. There is a
clinical perception, which has not been systematically
studied, that a feeling of perceived injustice is associated
with poor recovery in chronic pain disorders [19].
- Mindfulness: This concept is defined as the practice
of being mindful, focused on the present moment and
without judging the situation we have to live through
[20]. It has been demonstrated that mindfulness corre-
lates positively with several measures of psychological
well-being and that it is associated with significant long-
term improvement in patients with pain and, specifi-
cally, in FM [20,21].
- Positive and negative affect: Affect has been
described as the observable expression of emotion,
which can be both positive and negative [22,23]. Nega-
tive affect has been related with poor outcomes in FM
[22,23], but recently the emphasis has been put on the
affect balance style (relative levels of negative and posi-
tive affect) as a prognostic marker in FM [24].
It is not currently known whether these psychological
constructs correlate between themselves or even overlap
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prognosis and treatment on chronic pain disorders has
not been assessed. The general aim of this study is to
assess the importance of pain-related psychological con-
s t r u c t so nf u n c t i o na n dp a in in patients with FM. The
specific objective is to assess correlations and possible
overlapping among constructs.
Methods/Design
Design
Multicentric, naturalistic, one-year follow-up study.
Setting and study sample
Patients will be recruited from any of the primary care
health centres in the region of Aragon, Spain. General
practitioners will include patients with FM fulfilling the
s t u d yc r i t e r i au n t i lt h er e q u i r e ds a m p l ei sc o m p l e t e d ,
without a quota of patients assigned for each centre.
Patients considered for inclusion are those aged 18-65
years, able to understand and read Spanish, who fulfil
criteria for primary FM according to the American Col-
lege of Rheumatology [1], with no previous psychologi-
cal treatment, and on providing signed informed
consent. Those excluded will be patients with severe
Axis I psychiatric disorders (dementia, schizophrenia,
paranoid disorder, alcohol and/or drug use disorders),
severe Axis II disorders or somatic disorders which,
from the clinician’s point of view, prevent patients from
carrying out a psychological assessment.
Measurements
The variables and instruments of measurement are sum-
marized in Table 1.
Main outcome variables
- Fibromyalgia Impact Questionnaire (FIQ) [25]: The
FIQ is a 10-item self-report questionnaire developed to
measure the health status of FM patients. The first item
focuses on the patient’s ability to carry out muscular
activities. In the next two items, patients are asked to
circle the number of days in the past week they felt
good and how often they missed work. Finally, the last
seven questions (job ability, pain, fatigue, morning tired-
ness, stiffness, anxiety and depression) are measured by
a visual analogue scale (VAS). The Spanish validated
version will be used [26].
- Pain Visual Analogue Scale (PVAS): The PVAS was
designed to allow a thorough and understandable sub-
jective assessment of pain. A Visual Analogue Scale is
usually a 10-cm horizontal line, with perpendicular lines
on the edges, defined as the extreme limits of pain
experience. Anchoring points at each edge are charac-
terised by verbal expressions such as “No pain” (accom-
panied by the number “0”) at one end and “maximum
pain ever experienced” (accompanied by the number
“100”) at the other end. The adequate psychometric
properties of PVAS have been demonstrated in previous
studies [27,28]. The Spanish validated version of this
questionnaire will be used [29].
- Pain threshold assessed by sphygmomanometer: the
sphygmomanometer, a universally used clinical test, has
been demonstrated to be helpful in the identification of
patients with FM [30]. It has been recommended that
the blood pressure cuff be inflated at an approximate
rate of 10 mm Hg per second up to 180 mm Hg or to
the point where pain is elicited. Healthy persons usually
experience pain when the blood pressure cuff is inflated
to 160 mm Hg or more; however, patients with FM
usually experience pain at 100-110 mm Hg or at even
lower pressure [30].
Secondary variables
Socio-demographic variables The following socio-
demographic data will be collected: sex, age, marital sta-
tus (single, married/relationship, separated/divorced, and
widowed), educational level (no studies, primary, lower
secondary, upper secondary, and university), occupation
and income. In addition, relevant clinical variables
(family and personal medical and psychiatric history,
length of the disorder, main symptoms and medical
comorbidity) will be also assessed.
Pain-related psychological constructs - Pain catastro-
phizing: One of the most used questionnaires for mea-
suring this construct is the Pain Catastrophizing Scale
[13]. This is a self-administered 13-item questionnaire
that assesses three dimensions: rumination, magnifica-
tion and helplessness. Each item is scored from 0 (not
at all) to 4 (always), and total scores range from 0 to 52.
It has good temporal stability, internal consistency and
validity. The Spanish validated version will be used [31].
- Pain acceptance [15,16]: This variable is assessed
with the Chronic Pain Acceptance Questionnaire [15].
This is 20-item self-administered inventory. There are
two principle factors measured by this questionnaire:
activities engagement and pain willingness. All items are
rated on a 0 (never true) to 6 (always true) scale. The
maximum possible total score is 120, with a higher
score indicating better acceptance. The Spanish vali-
dated version will be used [32].
- Mental defeat [17]: This concept will be evaluated
with the Pain Self-Perception Scale. This is a 24-item
self-administered questionnaire. These statements are to
be rated on a 5-point scale (0 = “Not at all/Never”,1=
“Very little”,2=“Moderately”,3=“Strongly”,4=“Very
strongly”), generating a total score ranging from 0 to 96.
The Spanish validated version will be used [33].
- Pain psychological inflexibility [34]: the Psychology
Inflexibility in Pain Scale (PIPS) has been developed to
assess this core construct in ACT. It is a 16-item self-
administered instrument, with two main factors labelled
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asked to rate how true these statements are on a 7-
point Likert-type scale that ranges from ‘’never true’’ to
‘’always true’’, with higher scores indicating more psy-
chological inflexibility. Its psychometric properties are
considered adequate. We will validate a Spanish version
of this test on an independent sample to be used in the
study.
- Perceived injustice: a 12-item self-report measure, the
Injustice Experience Questionnaire (IEQ) [19], was devel-
oped to measure this concept. It addresses the degree to
which individuals perceive their post-disorder life as
being characterized by injustice. Principal component
analysis yielded a two-component solution. These factors
were labelled “irreparability of loss” and “blame/unfair-
ness”. The psychometric properties of IEQ are considered
adequate. We will validate a Spanish version of this test
on an independent sample to be used in the study.
- Mindfulness: Several questionnaires have been used
to assess the concept of mindfulness. For this study
w ew i l lu s eo n eo ft h em o s tw i d e l yu s e d ,t h eM i n d f u l
Attention Awareness Scale [21]. This is a 15-item self-
administered questionnaire. Principal component analysis
yielded a one-factor solution. The respondents indicate
how frequently they have the experience described in
each statement using a 6-point Likert scale from 1
(almost always)t o6( almost never), where high scores
reflect more mindfulness. In an attempt to monitor for
socially-desirable responses, respondents are asked to
answer according to what “really reflects” their experi-
ence rather than what they think their experience
should be. The items are distributed across cognitive,
emotional, physical, interpersonal and general domains.
Psychometric properties of the questionnaire are ade-
quate [21]. A Spanish version of this test will be validated
on an independent sample to be used in the study.
-Positive and Negative Affect: This will be measured
with the Positive and Negative Affect Scale (PANAS)
[35]. The PANAS consists of 2 mood scales with 10
items each for the assessment of PA and NA. Scores for
each scale range from 0 to 50. The scales have been
shown to be internally consistent, uncorrelated and
stable over a 2-month period; good convergent and dis-
criminant validity have also been demonstrated [35].
The Spanish validated version will be used [36].
Other variables - Psychiatric diagnosis: This will be
performed with the MINI psychiatric interview [37], a
psychiatric interview developed by our group and exten-
sively used for the study of psychiatric disorders in pri-
mary care. It allows the use of DSM-IV diagnostic
criteria. We specifically assess the presence of Post-
traumatic Stress Disorders because it seems to be asso-
ciated with a worse prognosis [38].
- Hospital Anxiety Depression Scale (HADS): This is a
self-reported scale designed to screen for the presence
of depression and anxiety disorders in medically ill
patients. It contains 14 items rated on four-point Likert-
type scales. Two subscales assess depression and anxiety
independently (HADS-Dep and HADS-Anx, respec-
tively) [39]. Patients with 14 or more points in the com-
plete scale (or more than eight in either of the two
subscales) are considered “probable cases” of anxiety
Table 1 Study variables
Instrument Assessment area Time(s) of
assessments
Applied
by
Sociodemographic data form assistant Sex, age, marital status, educational level, occupation,
income
Baseline Research
Clinical variables Family & personal medical & psychiatric history,
length of the disorder, main symptoms, psychiatric
comorbidity
Baseline Research
SPPI psychiatric interview [37] Psychiatric diagnosis Baseline Psychiatrist
Pain catastrophizing scale [31] Severity of catastrophizing Baseline Research
Pain acceptance scale [32] Acceptation of pain Baseline Research
Pain Self-Perception Scale (PSPS) [33] Mental defeat Baseline Research
Psychological Inflexibility in Pain Scale (PIPS)
[34]
Pain psychological inflexibility Baseline Research
Injustice Experience Questionnaire (IEQ) [19] Perceived injustice Baseline Research
Mindful Attention Awareness Scale (MAAS) [21] Mindfulness Baseline Research
Positive & Negative Affect (PANAS) [36] Positive and Negative Affect Baseline Research
Hospital Anxiety Depression Scale (HADS) [40] Anxiety, depression Baseline Research
Fibromyalgia Impact Questionnaire [26] General function Baseline and follow-up Research
Pain Visual Analogue Scale (PVAS) [29] Pain Baseline and follow-up Research
Pain assessed by sphygmomanometer [30] Pain Baseline and follow-up Research
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questionnaire will be used [40].
Procedure
Patients diagnosed with FM will be recruited by GPs
from the selected health centres to fill the required sam-
ple. At baseline, trained researchers will administer
questionnaires to assess socio-demographic, main out-
come and other variables, and pain-related psychological
constructs. At one-year follow-up, other researchers
who will be blind to the results at baseline will adminis-
ter the main outcome variables to the same patients.
Statistical methods
Sample size
To calculate the sample size, it is necessary to know the
population that suffers from FM in the region of Ara-
gon. According to epidemiological studies [2] the preva-
lence of FM in Spain is 2-3%. The population of Aragon
is calculated at 1,250,000 inhabitants, and based on this
prevalence data the number of persons diagnosed with
FM could be 30,000 patients. With a confidence level of
95%, an estimated error of 5% and considering the most
unfavourable assumption (p =0 . 5 ) ,as a m p l eo f3 0 5
patients will be necessary, using an accuracy of 3%. EPI-
DAT 3.1 was used to calculate the sample size.
Analysis strategy
At baseline, means and standard deviations will be cal-
culated for continuous variables in the study in case of
normality, or medians and interquartile periods where
this hypothesis is not fulfilled. The Kolmogorov-Smirnov
test will be applied to ensure the adjustment of data to a
normal distribution.
The existence of differences in socio-demographic,
main outcome and other variables regarding pain-related
psychological constructs will be analysed. These differ-
ences will be studied using Chi Square test for qualita-
tive variables, with the Fisher test being utilized when
necessary. To determine the relationship between cate-
gorical variables with one or two levels and quantitative
variables, Student T test or variance analysis will be
used, respectively, for variables fulfilling the normality
hypothesis. For the remaining variables, non-parametric
tests such as Man-Whitney U or Kruskall-Wallis will be
used. To assess the predictive value of pain-related psy-
chological construct on main outcome variables at one-
y e a rf o l l o w - u p ,u s ew i l lb em a d eo fal o g i s t i cr e g r e s s i o n
analysis adjusted for socio-demographic and clinical
variables.
A Spearman Rho non-parametric correlation matrix
will be developed to determine the relationship between
pain-related psychological constructs and possible over-
lapping, including these constructs and the other vari-
ables, for the analysis of the significance of this matrix
and each one of the calculated correlations. Patients will
be grouped according to pain-related psychological con-
structs using cluster analysis, with a profile graph to
represent the results of this multivariant analysis. Data
will be analysed using the SPSS 15 statistical package.
Ethical aspects
Informed consent will be obtained from the participants
before commencing the study. Before they give their
consent, patients will be provided with a general over-
view of the aims and characteristics of the study. They
will also be informed that they will be participating
voluntarily, and that they can choose to withdraw at any
time with the guarantee that they will continue to
receive the treatment considered most appropriate by
their doctor. The study follows Helsinki Convention
norms and subsequent modifications, and the Declara-
tion of Madrid of the World Psychiatric Association.
The Study Protocol was approved by the Ethical Review
Board of the regional health authority (ref: PI09/041).
Forecast execution dates
Initial recruitment of patients: December 2010
Finalization of patient recruitment: September 2011
Finalization of patient monitoring period: September
2012
Publication of results: December 2012
Discussion
In recent years, the importance of cognitive and affective
aspects for the treatment of chronic pain, not only in
FM but also in other chronic pain diseases, has been
widely acknowledged [41]. Furthermore, the effect of
specific psychological constructs or pain-coping activ-
ities such as catastrophizing on the functioning of neu-
romuscular, immune and neuroendocrine systems is
becoming an important subject in pain research [42].
Many of these constructs have been described and ques-
tionnaires for their assessment have been developed
[43]. However, the importance of these constructs, the
relationship and possible overlapping between them, or
the exact meaning of them in pain are not enough
known. For instance, pain acceptance seems to be a
more general concept that includes acceptance of other
kinds of unpleasant experiences, and it seems that gen-
eral acceptance and not only pain acceptance could
have positive effects on pain [44]. We consider this
study thoroughly analyses the effect of a wide set of
pain-related psychological constructs for the first time,
allowing their effect on pain and function in chronic
pain disorders to be understood.
Some possible limitations could be that recruitment,
despite being randomized, may not include enough
patients scoring positively in some of the psychological
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died. Another limitation is that, for some experts, the
very concept of some of these constructs such as cata-
strophizing has been criticized, suggesting the need of
new tools to assess them [45].
Acknowledgements
The study will be funded by a grant from the Carlos III Health Institute of
the Spanish Ministry of Health and Consumption (ETES n° PI09/90301).
Author details
1Servicio de Psiquiatría, Hospital Miguel Servet y Universidad de Zaragoza,
Spain.
2Centro Rodero. Clínica de Neurociencias, Santander, Spain.
3Departamento de Psicología. Universidad de Zaragoza, Spain.
4Parc Sanitari
Sant Joan de Déu & Fundació Sant Joan de Déu. Sant Boi de Llobregat,
Barcelona, Spain.
5CIBER Epidemiología y Salud Pública, Unidad
Epidemiología Clínica, Hospital 12 de Octubre, Madrid, Spain.
6Institut
Universitari d’Investigació en Ciències de la Salut, Hospital Juan March,
Universitat de les Illes Balears, Palma de Mallorca, Baleares, Spain.
7Grupo de
Bioinformación. Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain.
8Psicóloga. Asociación Aragonesa de Fibromialgia y Fatiga Crónica, Zaragoza,
Spain.
9Grupo Aragonés de Investigación en Atención Primaria, Red de
Actividades Preventivas y de Promoción de la Salud (REDIAPP) (G06/170).
Instituto Aragonés de Ciencias de la Salud (IACS), Aragon, Spain.
Authors’ contributions
JGC, JVL, BR and MR are the principal researchers and developed the
original idea for the study. The study design was further developed by SM,
YLH, RMB and YRL participated in the design and planning of the
intervention that is evaluated here. EA developed the statistical methods. All
authors have read and corrected draft versions, and approved the final
version.
Competing interests
The authors declare that they have no competing interests.
Received: 25 December 2010 Accepted: 8 January 2011
Published: 8 January 2011
References
1. Wolfe J, Smythe HA, Yunus MB, Bennet RM, Bombardier C, Goldenberg DL:
American College of Rheumatology 1990. Criteria for the Classification
of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthr
Rheum 1990, 33:160-172.
2. Valverde M, Juan A, Ribas B, Benito Urbina JC, Carmona I, y grupo de
trabajo EPISER 2000: Prevalencia de la fibromialgia en la población
española. Estudio EPISER 2000. Rev Esp Reumatol 2000, 27:157.
3. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and
characteristics of fibromyalgia in the general population. Arthritis Rheum
1995, 38:19-28.
4. Felix FH, Fontenele JB: The OLETF rat as a model of central sensitization:
possible relevance to the study of fibromyalgia and related diseases. J
Pharmacol Sci 2007, 105:372.
5. García Campayo J, Magdalena J, Magallón R, Fernández-Garcia E, Salas M,
Andrés E: A meta-analysis of the efficacy of fibromyalgia treatment
according to level of care. Arthritis Res Ther 2008, 10:R81.
6. Salaffi F, Sarzi-Puttini P, Girolimetti R, Atzeni F, Gasparini S, Grassi W: Health-
related quality of life in fibromyalgia patients: a comparison with
rheumatoid arthritis patients and the general population using the SF-
36 health survey. Clin Exp Rheumatol 2009, 27(5 Suppl 56):S67-74.
7. Rivera J, Rejas J, Esteve-Vives J, Vallejo MA, Group ICAF: Resource utilisation
and health care costs in patients diagnosed with fibromyalgia in Spain.
Clin Exp Rheumatol 2009, 27(5 Suppl 56):S39-45.
8. Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH:
Functional imaging of pain in patients with primary fibromyalgia. J
Rheumatol 2004, 31:364-378.
9. García-Campayo J, Fayed N, Serrano-Blanco A, Roca M: Brain dysfunction
behind functional symptoms: neuroimaging and somatoform,
conversive, and dissociative disorders. Curr Opin Psychiatry 2009,
22:224-31.
10. Fayed N, Garcia-Campayo J, Magallón R, Andrés-Bergareche H, Luciano JV,
Andres E, Beltrán J: Localized 1 H NMR spectroscopy in patients with
Fibromyalgia. Changes in cerebral glutamate/glutamine, inositol, choline
and N-acetylaspartate: a controlled study. Arth Res & Ther 2010, 12:R134.
11. Garcia-Campayo J, Pascual A, Alda M, Gonzalez Ramirez MT: Coping with
fibromialgia: usefulness of the Chronic Pain Coping Inventory-42. Pain
2007, 132(Suppl 1):S68-76.
12. Bennett R, Nelson D: Cognitive behavioral therapy for fibromyalgia. Nat
Clin Pract Rheumatol 2006, 2:416-24.
13. Sullivan MJL, Bishop S, Pivik J: The Pain Catastrophizing Scale:
development and validation. Psychol Assess 1995, 7:524-32.
14. Graceley RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA,
Claw DJ: Pain catastrophizing and neural responses to pain among
person with fibromialgia. Brain 2004, 127:835-43.
15. McCracken LM: Learning to live with the pain: acceptance of pain
predicts adjustment in persons with chronic pain. Pain 1998, 74:21-7.
16. Vowles KE, Eccleston C: Acceptance of chronic pain: component analysis
and a revised assessment method. Pain 2004, 107:159-66.
17. Tang NKY, Salkovskis PM, Hanna M: Mental defeat in chronic pain: initial
exploration of the concept. Clin J Pain 2007, 23:222-232.
18. Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J: Acceptance and
commitment therapy: model, processes and outcomes. Behav Res Ther
2006, 44:1-25.
19. Sullivan MJL, Adams H, Horan S, Maher D, Boland D, Gross R: The Role of
Perceived Injustice in the Experience of Chronic Pain and Disability:
Scale Development and Validation. J Occup Rehab 2008, 18:249-61.
20. Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U: Mindfulness training
as an intervention for fibromyalgia: evidence of postintervention and 3-
year follow-up benefits in well-being. Psychother Psychosom 2007,
76:226-33.
21. Brown KW, Ryan RM: The benefits of being present: mindfulness and its
role in psychological well-being. J Pers Soc Psychol 2003, 84:822-48.
22. Staud R, Price DD, Robinson ME, Vierck CJ Jr: Body pain area and pain-
related negative affect predict clinical pain intensity in patients with
fibromyalgia. J Pain 2004, 5:338-43.
23. Staud R, Vierck CJ, Robinson ME, Price DD: Overall fibromyalgia pain is
predicted by ratings of local pain and pain related negative affect:
possible role of peripheral tissues. Rheumatology (Oxford) 2006,
45:1409-15.
24. Hasset AL, Simonelli LE, Radvanski DC, Buyske S, Savage SV, Sigal LH: The
relationship between affect balance style and clinical outcomes in
fibromyalgia. Arthritis Rheum 2008, 59:833-40.
25. Burckhardt CS, Clark SR, Bennet RM: The Fibromyalgia Impact
Questionnaire: development and validation. J Rheumatol 1991,
18:728-733.
26. Rivera J, Gonzalez T: The Fibromyalgia Impact Questionnaire: a validated
Spanish version to assess the health status in women with fibromyalgia.
Clin Exp Rheumatol 2004, 22:554-60.
27. Huskisson EC: Visual analog scales. In Pain measurement and assessment.
Edited by: Melzack R. New York, Raven; 1983:33-37.
28. Sriwatanakul K, Kelvie W, Lasagna L: Studies with different types of visual
analog scales for measurement of pain. Clin Phrmacol Ther 1983,
34:234-239.
29. Garcia Campayo J: Advances in psychometrics Madrid: Soda; 2006.
30. Vargas A, Vargas A, Hernández-Paz R, Sánchez-Huerta JM, Romero-
Ramírez R, Amezcua-Guerra L, Kooh M, Nava A, Pineda C, Rodríguez-Leal G,
Martínez-Lavín M: Sphygmomanometry-evoked allodynia- as imple
bedside test indicative of fibromyalgia: a multicenter developmental
study. J Clin Rheumatol 2006, 12:272-4.
31. García Campayo J, Rodero B, Alda M, Sobradiel N, Montero J, Moreno S:
Validación de la versión española de la Pain Catastrophizing Scale en
pacientes con fibromialgia. Med Clin (Barc) 2008, 131:487-92.
32. Rodero B, García-Campayo J, Casanueva B, del Hoyo YL, Serrano-Blanco A,
Luciano JV: Validation of the Spanish version of the Chronic Pain
Acceptance Questionnaire (CPAQ) for the assessment of acceptance in
fibromyalgia. Health Qual Life Outcomes 2010, 8:37.
33. García-Campayo J, Rodero B, López del Hoyo Y, Luciano JV, Alda M, Gili M:
Validation of a Spanish language version of the Pain Self-Perception
Scale in patients with fibromyalgia. BMC Muskuloskeletal disorders .
Maurel et al. BMC Musculoskeletal Disorders 2011, 12:4
http://www.biomedcentral.com/1471-2474/12/4
Page 6 of 734. Wicksell RK, Renöfält J, Olsson GL, Bond FW, Melin L: Avoidance and
cognitive fusion - Central components in pain related disability?
Development and preliminary validation of the Psychological Inflexibility
in Pain Scale (PIPS). European Journal of Pain 2008, 12:491-500.
35. Watson D, Clark LA, Tellegen A: Development and validation of brief
measures of positive and negative affect: the PANAS scales. J Pers Soc
Psychol 1988, 54:1063-70.
36. Sandín B, Chorot P, Lostao L, Joiner TE, Santed MA, Valiente RM: Escalas
PANAS de afecto positivo y negativo: Validación factorial y convergencia
transcultural. Psicothema 1999, 11:37-51.
37. Ferrando L, Franco L, Soto M, Bobes J, Soto O, Franco L, Gibert J: MINI
International Neuropsychiatric Intrerview. Instituto IAP Madrid 1998.
38. Ablinn JN, Cohen H, Neumann L, Kaplan Z, Buskila D: Copying stiles in
fibromyalgia: effect of comorbid postraumatic stress disorder. Rheumatol
Int 2008, 28:649-56.
39. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta
Psychiatr Scand 1983, 67:361-70.
40. Tejero A, Guimerá EM, Farré JM, Peri JM: Uso clíınico del HAD (Hospital
Anxiety and Depression Scale) en población psiquiátrica: un estudio de
su sensibilidad, fiabilidad y validez. Rev Dep Psiquiatr Fac Med Barc 1986,
13:233-8.
41. Vowles KE, McCracken LM, Eccleston C: Patient functioning and
catastrophizing in chronic pain: the mediating effects of acceptance.
Health Psychol 2008, 27(2 Suppl):S136-43.
42. Edwards RR, Campbell C, Jamison RN, Wiech K: The neurobiological
underpinnings of coping with pain. Curr Dir Psychol Sci 2009, 18:237-41.
43. Vowles KE, McCracken LM, Eccleston C: Processes of change in trteatment
for chronic pain: the contributions of pain, acceptance, and
catastrophizing. Eur J Pain 2007, 11:779-87.
44. McCracken LM, Zhao-O’Brien J: General psychological acceptance and
chronic pain: There is more to accept than the pain itself. Eur J Pain
2009, 4.
45. Tang NK, Salkovskis PM, Poplavskaya E, Wright KJ, Hanna M, Hester J:
Increased use of safety-seeking behaviours in chronic back pain patients
with high health anxiety. Behav Res Ther 2007, 45:2821-35.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2474/12/4/prepub
doi:10.1186/1471-2474-12-4
Cite this article as: Maurel et al.: Correlational analysis and predictive
validity of psychological constructs related with pain in fibromyalgia.
BMC Musculoskeletal Disorders 2011 12:4.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Maurel et al. BMC Musculoskeletal Disorders 2011, 12:4
http://www.biomedcentral.com/1471-2474/12/4
Page 7 of 7